Invoking MCP tool get_drug_info with input {"drug_names":"PEGINTERFERON ALFA-2A"}
MCP tool get_drug_info returned meta=None content=[TextContent(type='text', text='{
  "name": "PEGINTERFERON LAMBDA-1A",
  "conceptId": "ncit:C166435",
  "approved": false,
  "immunotherapy": false,
  "antiNeoplastic": true,
  "drugAttributes": [],
  "drugApprovalRatings": [
    {
      "rating": "Max Phase 3",
      "source": {
        "sourceDbName": "ChEMBL",
        "sourceTrustLevel": {
          "level": "Expert curated"
        }
      }
    }
  ]
}', annotations=None, meta=None), TextContent(type='text', text='{
  "name": "PEGINTERFERON ALFACON-1",
  "conceptId": "drugbank:DB05860",
  "approved": false,
  "immunotherapy": false,
  "antiNeoplastic": false,
  "drugAttributes": [
    {
      "name": "Drug Class",
      "value": "protein"
    },
    {
      "name": "Indication",
      "value": "for treatment of hepatitis C"
    }
  ],
  "drugApprovalRatings": [
    {
      "rating": "Not Approved",
      "source": {
        "sourceDbName": "TdgClinicalTrial",
        "sourceTrustLevel": null
      }
    }
  ]
}', annotations=None, meta=None), TextContent(type='text', text='{
  "name": "PEGINTERFERON ALFA-2B",
  "conceptId": "rxcui:253453",
  "approved": true,
  "immunotherapy": false,
  "antiNeoplastic": true,
  "drugAttributes": [
    {
      "name": "Year of Approval",
      "value": "2001"
    }
  ],
  "drugApprovalRatings": [
    {
      "rating": "Approved",
      "source": {
        "sourceDbName": "HemOnc",
        "sourceTrustLevel": {
          "level": "Expert curated"
        }
      }
    },
    {
      "rating": "Max Phase 4",
      "source": {
        "sourceDbName": "ChEMBL",
        "sourceTrustLevel": {
          "level": "Expert curated"
        }
      }
    }
  ]
}', annotations=None, meta=None), TextContent(type='text', text='{
  "name": "PEGINTERFERON ALFACON-2",
  "conceptId": "ncit:C166720",
  "approved": false,
  "immunotherapy": false,
  "antiNeoplastic": true,
  "drugAttributes": [],
  "drugApprovalRatings": []
}', annotations=None, meta=None), TextContent(type='text', text='{
  "name": "PEGINTERFERON ALFA-2A",
  "conceptId": "rxcui:120608",
  "approved": true,
  "immunotherapy": true,
  "antiNeoplastic": true,
  "drugAttributes": [
    {
      "name": "Year of Approval",
      "value": "1986"
    },
    {
      "name": "Year of Approval",
      "value": "2002"
    },
    {
      "name": "Drug Class",
      "value": "recombinant protein"
    },
    {
      "name": "Indication",
      "value": "Antineoplastic Agents; Immunomodulatory Agents"
    },
    {
      "name": "Drug Class",
      "value": "Immunomodulatory Agents"
    },
    {
      "name": "Drug Class",
      "value": "Antineoplastic Agents"
    },
    {
      "name": "Drug Class",
      "value": "protein"
    },
    {
      "name": "Indication",
      "value": "for treatment of hepatitis B and C"
    }
  ],
  "drugApprovalRatings": [
    {
      "rating": "Prescribable",
      "source": {
        "sourceDbName": "RxNorm",
        "sourceTrustLevel": {
          "level": "Expert curated"
        }
      }
    },
    {
      "rating": "Approved",
      "source": {
        "sourceDbName": "HemOnc",
        "sourceTrustLevel": {
          "level": "Expert curated"
        }
      }
    },
    {
      "rating": "Approved",
      "source": {
        "sourceDbName": "TdgClinicalTrial",
        "sourceTrustLevel": null
      }
    },
    {
      "rating": "Max Phase 4",
      "source": {
        "sourceDbName": "ChEMBL",
        "sourceTrustLevel": {
          "level": "Expert curated"
        }
      }
    }
  ]
}', annotations=None, meta=None), TextContent(type='text', text='{
  "name": "PEGINTERFERON BETA-1A",
  "conceptId": "rxcui:1546168",
  "approved": true,
  "immunotherapy": false,
  "antiNeoplastic": true,
  "drugAttributes": [],
  "drugApprovalRatings": [
    {
      "rating": "Prescribable",
      "source": {
        "sourceDbName": "RxNorm",
        "sourceTrustLevel": {
          "level": "Expert curated"
        }
      }
    },
    {
      "rating": "Max Phase 4",
      "source": {
        "sourceDbName": "ChEMBL",
        "sourceTrustLevel": {
          "level": "Expert curated"
        }
      }
    }
  ]
}', annotations=None, meta=None)] structuredContent=None isError=False
### LLM OUTPUT ###
fda_approval,immunotherapy,anti_neoplastic
YES,YES,YES
